Tehran University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the A Randomized, Two-Armed, Double-Blind, Single-Dose, Cross-Over, Bioequivalence Clinical Trial to Compare Pharmacokinetic Parameters and Safety of Recombinant Human Factor Viii With Fc Fusion Produced by Aryogen Pharmed Company Versus Elocta® (Reference Product) in Previously Treated Patients With Severe Haemophilia A
Ehsan Taghiabadi
Ehsan Taghiabadi

Assistant Professor of Applied Cellular Sciences

Skin and Stemcell Research Center

Tehran University of Medical Sciences

All Documents
6. Phenotypic Continuum of Nfu1-Related Disorders, Annals of Clinical and Translational Neurology (2022)
12. Engineering the Niche for Hair Regeneration — a Critical Review, Nanomedicine: Nanotechnology# Biology# and Medicine (2019)
14. Regenerative Medicine Applications in Wound Care, Current Stem Cell Research and Therapy (2017)